Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONTAK in previously treated CLL
NCT00055146Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2003
- Primary completion
- Mar 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 2 trial of denileukin diftitox in chronic lymphocytic leukemia (CLL), sponsored by Eisai Co., Ltd.. Started Mar 2003; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00055146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055146.